SG Americas Securities
STLN

SG Americas Securities’s Starling Oncology STLN Stock Holding History

SG Americas Securities’s Portfolio STLN Stock Details STLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.43M Buy
263,147
+249,049
+1,767% +$1.05M ﹤0.01% 1668
2026
Q1 		$43K Sell
14,098
-2,039
-13% -$6.25K ﹤0.01% 3037
2025
Q4 		$57K Sell
16,137
-12,208
-43% -$45.3K ﹤0.01% 3340
2025
Q3 		$99K Buy
+28,345
New +$97.1K ﹤0.01% 3090
2023
Q2 		– Sell
-14,740
Closed -$10K – 3155
2023
Q1 		$10K Buy
+14,740
New +$18.8K ﹤0.01% 3186

Other funds holding STLN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JAIC
Josh Arnold Investment Consultant Edina, Minnesota $159M AUM 142.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

SG Americas Securities's STLN Position: Q2 2026 in Review

SG Americas Securities increased its Starling Oncology (STLN) stake by 1,767% in Q2 2026, buying an estimated $1.05M and bringing the position to 263,147 shares worth $1.43M. The position accounts for ﹤0.01% of the portfolio, ranked #1668.

SG Americas Securities first reported a position in STLN in Q1 2023 and has held it in 5 quarters since. 119 funds tracked by Wall St. Rank hold STLN as of Q2 2026.

  • SG Americas Securities held 263,147 shares of Starling Oncology worth $1.43M as of Q2 2026.
  • SG Americas Securities bought 249,049 Starling Oncology shares in Q2 2026, an estimated $1.05M.
  • Starling Oncology made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #1668 holding.
  • SG Americas Securities first reported a position in Starling Oncology in Q1 2023 and has held it in 5 quarters since.
  • 119 funds tracked by Wall St. Rank held Starling Oncology as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.